Literature DB >> 4206861

Letter: CCNU in teatment of recurrent medulloblastoma.

H W Ward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4206861      PMCID: PMC1633445          DOI: 10.1136/bmj.1.5908.642-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  1 in total

1.  Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).

Authors:  H H Hansen; O S Selawry; F M Muggia; M D Walker
Journal:  Cancer Res       Date:  1971-03       Impact factor: 12.701

  1 in total
  5 in total

1.  CNS Anticancer Drug Discovery and Development Conference White Paper.

Authors:  Victor A Levin; Peter J Tonge; James M Gallo; Marc R Birtwistle; Arvin C Dar; Antonio Iavarone; Patrick J Paddison; Timothy P Heffron; William F Elmquist; Jean E Lachowicz; Ted W Johnson; Forest M White; Joohee Sul; Quentin R Smith; Wang Shen; Jann N Sarkaria; Ramakrishna Samala; Patrick Y Wen; Donald A Berry; Russell C Petter
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

2.  Prospective randomized cooperative medulloblastoma trial (MED 84) of the International Society of Paediatric Oncology (SIOP) and of the (German) Society of Paediatric Oncology (GPO).

Authors:  M K Neidhardt; C C Bailey
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

Review 3.  The chemotherapy of posterior fossa tumors in childhood.

Authors:  H S Friedman; W J Oakes
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

4.  Intra-arterial BCNU in the treatment of recurrent medulloblastoma.

Authors:  K Watne; B Hager; H Hirschberg
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

5.  Medulloblastoma in childhood.

Authors:  A J Raimondi; T Tomita
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.